ANNETTE TERZO: Open Payments
NPI 1376877209 · LONG BRANCH, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$521 in 27 payments from 18 companies in 2025. Trend: 2023 $237 · 2024 $663 · 2025 $521
Food & beverage: $499Education: $23
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $63 |
| Daiichi Sankyo Inc. | 3 | $56 |
| E.R. Squibb & Sons, L.L.C. | 3 | $56 |
| Novartis Pharmaceuticals Corporation | 2 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| Pharmacosmos Therapeutics Inc. | 2 | $38 |
| Adaptive Biotechnologies Corporation | 1 | $26 |
| Azurity Pharmaceuticals, Inc. | 1 | $23 |
| Janssen Biotech, Inc. | 1 | $20 |
| TAIHO ONCOLOGY, INC. | 1 | $19 |
Products named: OJJAARA, Nubeqa, MONOFERRIC, OPDUALAG, INJECTAFER, Fabhalta, clonoSEQ, DANZITEN.
Industry payments across NJ — which companies pay providers there.
